cinacalcet
| SMILES | C[C@H](c1cccc2c1cccc2)NCCCc1cccc(c1)C(F)(F)F |
| InChIKey | VDHAWDNDOKGFTD-MRXNPFEDSA-N |
Chemical properties
| Hydrogen bond acceptors | 1 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 6 |
| Molecular weight (Da) | 357.2 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| mGlu5 | GRM5 | Rat | Metabotropic glutamate | C | pKi | 4.35 | 4.35 | 4.35 | Guide to Pharmacology |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 5.8 | 5.8 | 5.8 | ChEMBL |
| 5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 7.4 | 7.4 | 7.4 | ChEMBL |
| 5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 6.18 | 6.18 | 6.18 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 5.71 | 5.71 | 5.71 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pKi | 6.41 | 6.41 | 6.41 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pKi | 6.35 | 6.35 | 6.35 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pKi | 5.89 | 5.89 | 5.89 | ChEMBL |
| mGlu5 | GRM5 | Rat | Metabotropic glutamate | C | pKi | 8.36 | 8.36 | 8.36 | Drug Central |
| 5-HT1D | 5HT1D | Human | 5-Hydroxytryptamine | A | pKi | 5.77 | 5.77 | 5.77 | ChEMBL |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.08 | 6.08 | 6.08 | ChEMBL |
| 5-HT5A | 5HT5A | Human | 5-Hydroxytryptamine | A | pKi | 6.01 | 6.01 | 6.01 | ChEMBL |
| 5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pKi | 5.74 | 5.74 | 5.74 | ChEMBL |
| 5-HT7 | 5HT7R | Human | 5-Hydroxytryptamine | A | pKi | 6.24 | 6.24 | 6.24 | ChEMBL |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 5.54 | 5.54 | 5.54 | ChEMBL |
| H2 | HRH2 | Human | Histamine | A | pKi | 5.58 | 5.58 | 5.58 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| CaS | CASR | Human | Calcium-sensing | C | pEC50 | 7.3 | 7.3 | 7.3 | Guide to Pharmacology |
| CaS | CASR | Human | Calcium-sensing | C | pKB | 5.9 | 6.25 | 6.6 | Guide to Pharmacology |
| FPR3 | FPR3 | Human | Formylpeptide | A | pIC50 | 5.4 | 5.4 | 5.4 | ChEMBL |
| GPR183 | GP183 | Human | Orphan | A | pIC50 | 5.44 | 5.44 | 5.44 | ChEMBL |
| CaS | CASR | Human | Calcium-sensing | C | pEC50 | 6.75 | 7.49 | 8.4 | ChEMBL |
| CaS | CASR | Human | Calcium-sensing | C | pIC50 | 5.55 | 5.55 | 5.55 | ChEMBL |
| GPR35 | GPR35 | Human | Orphan | A | pIC50 | 5.47 | 5.47 | 5.47 | ChEMBL |
| CaS | CASR | Human | Calcium-sensing | C | pEC50 | 8.11 | 8.11 | 8.11 | Drug Central |
| FPR1 | FPR1 | Human | Formylpeptide | A | pIC50 | 5.1 | 5.1 | 5.1 | ChEMBL |